GSMG(SH:600543)2024-10-30 08:41Financial Performance - The company's operating revenue for Q3 2024 was ¥63,298,441.82, representing a year-on-year increase of 21.53%[2] - The net profit attributable to shareholders was -¥18,010,393.88, with a year-to-date net profit of -¥27,238,268.63[2] - Total operating revenue for the first three quarters of 2024 reached ¥224,501,623.09, a significant increase from ¥138,944,431.29 in the same period of 2023, representing a growth of approximately 61.5%[15] - The net profit for the first three quarters of 2024 was a loss of ¥27,214,556.11, worsening from a loss of ¥24,613,468.09 in the same period of 2023[16] - Basic earnings per share for Q3 2024 were -0.08 CNY, compared to -0.07 CNY in Q3 2023[17] Cash Flow - The net cash flow from operating activities was ¥4,107,076.36, a significant improvement compared to -¥43,342,652.12 in the previous year[3] - Net cash flow from operating activities for the first three quarters of 2024 was -43,342,652.12 CNY, a decline from -10,176,793.48 CNY in the same period of 2023[18] - The company reported a total cash outflow from operating activities of 213,681,966.29 CNY in the first three quarters of 2024, compared to 163,608,434.35 CNY in 2023[18] - The ending cash and cash equivalents balance for Q3 2024 was 32,562,452.03 CNY, down from 200,551,186.45 CNY in the previous year[19] - The company’s cash flow from operating activities showed a significant deterioration, indicating potential challenges in operational efficiency[18] Assets and Liabilities - The total assets at the end of the reporting period were ¥965,241,611.38, down 5.83% from the previous year[3] - The company's total current assets as of September 30, 2024, amount to ¥348,298,383.20, a decrease from ¥416,520,898.92 at the end of 2023[10] - The total liabilities decreased to ¥124,660,926.91 in Q3 2024 from ¥145,257,726.17 in Q3 2023, reflecting a reduction of approximately 14.2%[14] - The total equity attributable to shareholders decreased to ¥834,456,971.95 in Q3 2024 from ¥879,695,227.42 in Q3 2023, a decline of about 5.1%[14] - The total assets of the company are ¥965,241,611.38, down from ¥1,024,952,953.59 at the end of 2023[12] Revenue and Costs - The company reported a 61.58% increase in operating income year-to-date, driven by enhanced R&D and market expansion efforts in biodegradable materials and pharmaceuticals[6] - Total operating costs for the first three quarters of 2024 were ¥249,078,456.16, compared to ¥158,830,485.21 in 2023, indicating an increase of about 56.7%[15] Shareholder Information - The total number of common shareholders at the end of the reporting period is 29,445[8] - The largest shareholder, Gansu Agricultural Reclamation Group Co., Ltd., holds 52,192,036 shares, accounting for 16.25% of total shares[8] - There are no significant changes in the shareholding structure of the top ten shareholders compared to the previous period[9] Research and Development - Research and development expenses for the first three quarters of 2024 were ¥1,334,028.17, slightly down from ¥1,584,336.22 in the same period of 2023, indicating a decrease of approximately 15.7%[15] Government Support and Other Income - The company received government subsidies amounting to ¥322,818.88 during the reporting period, contributing to a 40.03% increase in other income[7] Investment Activities - The cash flow from investing activities increased by ¥2,410,180.00, mainly due to the recovery of matured large-denomination bank certificates[7] - Total cash inflow from investment activities in Q3 2024 was 140,062,097.35 CNY, compared to 600.00 CNY in the previous period[19] - Cash outflow from investment activities totaled 116,976,442.69 CNY in Q3 2024, significantly higher than 1,016,732.88 CNY in the same period last year[19] - The company received 6,100,000.00 CNY from investments in Q3 2024, indicating ongoing capital inflow[19] Future Outlook - The company plans to focus on market expansion and new product development to improve future performance and profitability[16]